Known targets — ChEMBL curated mechanism
GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQ
The experimentally established mechanism targets of Propofol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 known ✓ | P14867 | 4/20 | 0.63 |
| ▸ | GABRB1 known ✓ | P18505 | 2/20 | 0.63 |
| ▸ | GABRG2 known ✓ | P18507 | 2/20 | 0.63 |
| ▸ | GABRB3 known ✓ | P28472 | 2/20 | 0.63 |
| ▸ | GABRB2 known ✓ | P47870 | 2/20 | 0.63 |
| ▸ | GABRA5 known ✓ | P31644 | 1/20 | 0.63 |
| ▸ | GABRA3 known ✓ | P34903 | 1/20 | 0.63 |
| ▸ | GABRA2 known ✓ | P47869 | 1/20 | 0.63 |
| ▸ | GABRA4 known ✓ | P48169 | 1/20 | 0.63 |
| ▸ | GABRA6 known ✓ | Q16445 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 3/20 | 0.63 |
| ▸ | FAAH | O00519 | 1/20 | 0.63 |
| ▸ | CA1 | P00915 | 1/20 | 0.63 |
| ▸ | CA2 | P00918 | 1/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | HPGD | P15428 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.63 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propofol SCHEMBL6535668 | 0.96 | GABRA1 (0.63) | GABRA1LMNAGABRB1GABRG2GABRB3 | |
| Propofol SCHEMBL4126066 | 0.92 | GABRA1 (0.68) | GABRA1LMNAGABRB1GABRG2GABRB3 | |
| Propofol SCHEMBL28945844 | 0.90 | GABRA1 (0.55) | GABRA1LMNAGABRB1GABRG2GABRB3 | |
| Palmitic Acid SCHEMBL17372983 | 0.89 | GPR84 (0.53) | GABRA1LMNAGABRB1GABRG2GABRB3 | |
| Propofol SCHEMBL4023094 | 0.84 | GABRA1 (0.81) | GABRA1LMNAGABRB1GABRG2GABRB3 | |
| Propofol SCHEMBL23277006 | 0.83 | GABRA1 (0.65) | GABRA1LMNAGABRB1GABRG2GABRB3 | |
| Propofol SCHEMBL2678655 | 0.83 | GABRA1 (0.65) | GABRA1LMNAGABRB1GABRG2GABRB3 | |
| Oleic Acid SCHEMBL17372979 | 0.81 | PPARG (0.60) | LMNAFAAHCYP1A2CYP3A4HPGD | |
| Oleic Acid SCHEMBL28162453 | 0.81 | PPARG (0.60) | LMNAFAAHCYP1A2CYP3A4HPGD | |
| Propofol SCHEMBL6945747 | 0.80 | CYP1A2 (0.55) | GABRA1LMNAGABRB1GABRG2GABRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2586768-B1 | HYDROXY ACID ESTER OF PROPOFOL, PREPARATION METHOD AND MEDICAL USE | WEST CHINA HOSPITAL SICHUAN UNIV (CN) | 2018-06-27 | — | — | EP | disclosed |
| US-9272978-B2 | Hydroxy acid ester compound of substituted phenol, preparation method and medical use thereof | WEST CHINA HOSPITAL, SICHUAN UNIVERSITY (CN) | 2016-03-01 | — | — | US | disclosed |
| US-9243009-B2 | Phosphate ester compound of hydroxy acid substituted phenol ester, preparation method and medical use thereof | WEST CHINA HOSPITAL, SICHUAN UNIVERSITY (CN) | 2016-01-26 | — | — | US | disclosed |
| EP-2586785-B1 | PHOSPHORIC ACID ESTER COMPOUND OF HYDROXY ACID SUBSTITUTED PHENYL ESTER, SYNTHESIS METHOD AND MEDICAL USE THEREOF | WEST CHINA HOSPITAL SICHUAN UNIV (CN) | 2015-12-16 | — | — | EP | disclosed |
| EP-2586768-A1 | HYDROXY ACID COMPOUND OF SUBSTITUTED PHENYL ESTER, PREPARATION METHOD AND MEDICAL USE THEREOF | West China Hospital Sichuan University (CN) | 2013-05-01 | — | — | EP | disclosed |
| EP-2586785-A1 | PHOSPHORIC ACID ESTER COMPOUND OF HYDROXY ACID SUBSTITUTED PHENYL ESTER, SYNTHESIS METHOD AND MEDICAL USE THEREOF | West China Hospital Sichuan University (CN) | 2013-05-01 | — | — | EP | disclosed |
| US-20130085120-A1 | Phosphate Ester Compound of Hydroxy Acid Substituted Phenol Ester, Preparation Method and Medical Use Thereof | Yichang Humanwell Pharmaceutical Co., Ltd. (CN) | 2013-04-04 | — | — | US | disclosed |
| US-20130079405-A1 | Hydroxy Acid Ester Compound of Substituted Phenol, Preparation Method and Medical Use Thereof | WEST CHINA HOSPITAL SICHUAN UNIVERSITY (CN) | 2013-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130079405-A1 | Hydroxy Acid Ester Compound of Substituted Phenol, Preparation Method and Medical Use Thereof | CYP3A4, CYP2C19, CYP2A6 | GABRA1 285/4885GABRB1 384/4885GABRG2 669/4885 |
| US-20130085120-A1 | Phosphate Ester Compound of Hydroxy Acid Substituted Phenol Ester, Preparation Method and Medical Use Thereof | HPD, PAH, CYP3A4 | GABRA1 764/4885GABRB1 950/4885GABRG2 1838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.